«
»

Scientific guideline: Draft guideline on core SmPC for human normal immunoglobulin for subcutaneous and intramuscular administration, draft: consultation open

This guideline describes the information to be included in the Summary of Product Characteristics (SmPC) for human normal immunoglobulins for subcutaneous and/or intramuscular administration.
Go to Source

Share and Enjoy:
  • Add to favorites
  • email
  • Print
  • Twitter
  • Facebook
  • Digg
  • StumbleUpon
  • del.icio.us
  • Yahoo! Buzz
  • Google Bookmarks
  • Google Buzz
  • FriendFeed
  • LinkedIn
  • Live
  • Posterous
  • Reddit
  • Technorati
  • Wikio


This entry was posted on Tuesday, July 31st, 2012 at 11:30 am and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

Comments are closed.

Leave a Reply

You must be logged in to post a comment.

MySQL query error